![]() |
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
||
|
Books > Medicine > Clinical & internal medicine > Haematology
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more. Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more. Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Preview this title's catalog page in a new window 100 Questions & Answers About Von Willerbrand Disease First Edition Second Edition Third Edition Fourth Edition Fifth Edition Sixth Edition Seventh Edition Eighth Edition Ninth Edition Tenth Edition Eleventh Edition Twelve Edition Authors: Andra H. James , MD , Duke University Medical Center Show degrees: Yes No Show affiliations: Yes No ISBN: 0763757675 ISBN-13: 9780763757670 Price: $17.95 Binding: Paperback Pages: 114 Link for Request Review Copy: http://www.jbpub.com/cart/compcart.cfm?bc=5767-0&t= Will Publish: 05/21/2008 Copyright: Title Page Text [Edit] EMPOWER YOURSELF! The only text to provide both the patient's and doctor's views, 100 Questions & Answers About Von Willebrand Disease provides a much needed primer for patients and their families. This book address the questions most relevant to those recently diagnosed with the disease, offering up-to-date, authoritative, practical, yet easy to understand answers to your questions about Von Willebrand Disease, including indispensable information about diagnosis and treatment. VWD is a common bleeding disorder, affecting 1% of all people; this valuable resource will help those diagnosed better understand and cope with the disorder.
Cutting-edge scientific breakthroughs in treating hemophilia, including gene therapy and recombinant DNA technology, are described. Symptoms of the disease are also detailed, providing a clear picture of what it is like to live with this royal disease.
This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.
This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.
This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.
Revised and updated throughout, the 2nd Edition offers a concise, clinically focused and practical approach to the diagnosis and management of the full range of issues in transfusion and blood banking. The author reviews the most common disorders involving red blood cells, white blood cells and haemostasis and examines each disease state with discussions of underlying pathophysiology, clinical features, up-to-date lab tests and current management strategies. Presents the practice-proven experience of a leader in the field of pathology and hematology. Includes chapter summaries throughout for quick access to key guidance. Offers complete, quick access guidance on the full range of topics in blood bank and transfusion-from blood collection and storage...to testing and transfusing blood components...to cellular engineering. Discusses the latest developments, including HP growth factors and cellular engineering. Features a wealth of new illustrations and line drawings.
A-Z of Haematology provides an essential 'quick reference guide' to
definitions covering the entire spectrum of haematology, from blood
transfusion and coagulation through to recent advances in molecular
haematology. It is the indispensable guide for all those practising or
studying haematology including research scientists and biomedical
scientists working in diagnostic laboratories. Scientists working
in cytogenetics and immunophenotyping will also find it a valuable
repository of relevant knowledge.
A-Z of Haematology includes:
Presenting the new edition of the classic reference on paediatric haematology and oncology, this book, comprehensively revised and updated, continues to integrate lucid reviews of the pathophysiology of disease with detailed clinical guidance on its diagnosis and management. Drs. Nathan and Orkin - joined by two new co-editors and an outstanding team of authors - worked tirelessly to ensure that all the latest scientific advances appear in the sixth edition.
A portable, quick-reference guide with clinical information on over 100 hematologic diseases and their management. Based on the new Sixth Edition of Williams Hematology, the handbook presents concise information on etiology and pathogenesis, clinical and lab features, differential diagnosis, treatment, and prognosis.
Das 7. Heidelberger Symposium A1/4ber HAmostaseologie in der AnAsthesiologie hatte als zentrales Thema die disseminierte Gerinnungsaktivierung, wie sie bei Sepsis im Rahmen der Verbrauchskoagulopathie immer noch ein wichtiges klinisches Problem ist. Die disseminierte Gerinnungsaktivierung stellt sich immer wieder mit zwei Gesichtern dar: Zum einen ist sie ein Paradepferd der wissenschaftlichen HAmostaseologie, das Modell, an dem die Gerinnung erforscht wird, zum anderen ist sie immer wieder fA1/4r EnttAuschungen und Aoeberraschungen gut, denn kaum meint man, ein MolekA1/4l und seine Wirkung verstanden zu haben, so lehrt die klinische Erfahrung, dass dies nicht so einfach ist, wie man ursprA1/4nglich dachte.
Understanding the connections between culture, race, politics, and disease This groundbreaking book chronicles the history of sickle cell anemia in the United States, tracing its transformation from an ""invisible"" malady to a powerful, yet contested, cultural symbol of African American pain and suffering. Set in Memphis, where one of the nation's first sickle cell clinics was founded in the 1950s, Dying in the City of the Blues reveals how the recognition, treatment, social understanding, and symbolism of the disease evolved in the twentieth century, shaped by the politics of race, region, health care, and biomedicine. Using medical journals, patients' accounts, black newspapers, blues lyrics, and many other sources, Keith Wailoo follows the disease and its sufferers from the early days of obscurity before sickle cell's ""discovery"" by Western medicine; through its rise to clinical, scientific, and social prominence in the 1950s; to its politicization in the 1970s and 1980s. Looking forward, he considers the consequences of managed care on the politics of disease in the twenty-first century. A rich and multilayered narrative, Dying in the City of the Blues offers valuable new insight into the African American experience, the impact of race relations and ideologies on health care, and the politics of science, medicine, and disease.
Now expanded with new coverage of genetics, more therapy and management strategies, and more references throughout, this guide remains one of the most practical resources for diagnosis and treatment of hematologic conditions commonly seen in general practice. The clear, succinct language is meant for the non-hematologist who wants the salient points of clinical signs, etiology and pathophysiology, laboratory tests, differential diagnosis, and treatment in one convenient manual.
With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis. This trusted resource by Drs. Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, Michael B. Streiff, and David A. Garcia is designed for rapid reference and critical decision making at the point of care. Emphasizes real-world problems and solutions, with quick access to concise descriptions of each condition, associated symptoms, laboratory findings, differential diagnosis, and treatment. Features a user-friendly design, full-color format, abundant laboratory protocols, and at-a-glance tables and charts throughout. Provides thorough updates on core information on hemostasis and thrombosis, including deep venous thrombosis (DVT), pulmonary embolisms, hypercoagulability, thrombocytopenia, von Willenbrand disease, and more. Covers new treatment information on hemophilia A and B. Contains new chapters on hereditary hemorrhagic telangiectasia, hemolytic uremic syndrome, and paroxymal nocturnal hemoglobinuria. Two new editors, Dr. Michael B. Streiff and Dr. David A. Garcia, offer fresh perspectives and valuable experience. Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Hematological malignancies, defined as cancers that affect the blood, bone marrow, and lymph nodes, represent a serious health care challenge for oncologists. Chapter One focuses on cytogenetic and molecular markers and summarizes their importance in identification, treatment and prognosis in patients with myeloproliferative neoplasms. Chapter Two details the efficacy of treatment of myeloid hematologic malignancies with isocitrate dehydrogenase mutations by inhibitors of this enzyme. Chapter Three describes the use of Selinexor and other drugs for the treatment of hematologic malignancies. Chapter Four explains the utility of poly(ADP-ribose) polymerase inhibitors in the treatment of myelodysplastic syndrome and acute myeloid leukemia.
Zur Untersuchung des Einflusses von tubularem HIF auf die renale EPO-Produktion generierte Navid Farsijani ein genetisches Mausmodell, in dem durch tubulare Vhl-Ablation, tubulare Epithelzellen HIF uberexprimieren. Die tubulare Vhl-Ablation fuhrte zu einer prompten Suppression der renalen EPO-Produktion. Anhand weitere konditioneller Mausmodelle zeigt der Autor, dass die Entwicklung der Anamie von HIF-abhangig ist, proximale Tubuluszellen fur die Regulation von EPO im Nephron verantwortlich sind und die tubulare Vhl-Ablation mit einer Reduktion der mitochondrialen Masse sowie einer Erhoehung des kortikalen Gewebssauerstoffpartialdruckes (PtO2) einhergeht. Dies spricht fur eine multi-zellulare Regulation der renalen EPO-Synthese, in der eine Homoeostase zwischen tubularen Epithelzellen und REPC fur eine adaquate EPO-Produktion der Niere notwendig ist. Zudem koennte der EPO-suppressive Effekt von tubularem HIF einen pathophysiologischen Faktor in der Entstehung von renalen Anamien darstellen.
1m Verlauf der in den letzten Jahren und Jahrzehnten erzielten groBen Fortschritte der Pathophysiologie der BluteiweiBe wurde die Analyse der Plasmaproteine zu einem der aktuellsten Kapitel der modernen klinischen Laboratoriumsdiagnostik. Neben den Methoden der direkten chemischen und elektrophoretischen EiweiBbestimmung ist es vor allem das Phano- men der krankheitsbedingten Kolloidstabilitatsveranderung von Serum und Plasma, dessen diagnQstische Nutzbarmachung mit einem tiber- waltigenden Arbeitsaufwand von seiten zahlloser Forscher vorangetrie- ben wurde und standig weiter ausgebaut wird. Die hierbei beschrittenen Wege sind vielfaltig; sie entsprangen zum Teil sehr unterschiedlichen Fragestellungen und dienten den verschiedenartigsten praktischen Zwek- ken. Die Reihe der so im Laufe der Zeit fUr diagnostische Aufgaben in der Klinik (Leberfunktionsprtifung, Aktivitatsfeststellung bei Tuber- kulose und anderen entztindlichen Erkrankungen, Karzinomdiagnostik usw. ) entwickelten Kolloid-Labilitatsreaktionen des Blutes umfaBt be- reits tiber 250 Methoden. Die mit ihnen gesammelten Erkenntnisse brachten eine beachtliche Ausweitung unseres Wissens tiber die Humoral- pathologie des Blutes. Trotzdem ist das allgemeine Urteil tiber diesen Zweig der klinischen Diagnostik auch heute noch bemerkenswert un- einheitlich, und es bestehen tiber die wirkliche Leistungsfiihigkeit der sogenannten Labilitatsreaktionen vielerorts falsche Vorstellungen. Es sind dabei aIle Auffassungen zu finden von einer kritiklosen Dberschat- zung einerseits bis zur grundsatzlichen Ablehnung dieser Methoden an- dererseits. Infolge der Beteiligung fast aller Facher der Medizin an der Entwicklung der Kolloidstabilitatsdiagnostik des Blutes und der dadurch weit verstreuten einschlagigen Literatur ist die Verschaffung eines um- fassenderen Dberblicks tiber dieses Gebiet nicht einfach.
This book provides a highly illustrated and comprehensive account of the diseases of the human bone marrow. It will help experienced clinicians and those in training to answer the practical diagnostic questions that arise during the routine analysis of bone marrow core biopsy specimens. Throughout the text, histologic interpretation is integrated with clinical and laboratory findings. Emphasis is placed on the evaluation of peripheral blood, aspirate smear, clot section and core biopsy, as well as ancillary techniques including flow cytometry and immunohistochemistry in the diagnosis of hematologic disorders of the marrow. The text is illustrated with numerous color figures, charts and tables, and descriptions of real case situations using the most up-to-date classification systems. Illustrated Pathology of Bone Marrow should be read by all pathologists, hematologists and laboratory technicians involved in the analysis of bone marrow specimens.
Der vorliegende Band bietet eine umfassende Ubersicht uber hamatologische Neoplasien, ihre molekularmedizinischen Ursachen und deren Einfluss auf Diagnose und Therapie. Folgende Themenbereiche werden behandelt: 1. Hereditare Erkrankungen mit erhohtem Risiko fur hamatologische Neoplasien 2. Molekularbiologie sporadischer hamatologischer Neoplasien 3. Sporadische Leukamien 4. Sporadische Lymphome"
More than 2 billion people worldwide have some form of anemia. Even so, the condition is greatly misunderstood and often improperly treated. "The Iron Disorders Institute Guide to Anemia" contains everything a patient needs to know about the different forms of anemia, symptoms, treatment, and diet. It provides patients and family members with everything they need to be proactive with their physicians, including information about what doctors must do to differentiate between different causes and how each cause is treated.
Accurate analysis of blood gases is vital to give information on a patient's respiratory and circulation state as well as the adequacy of resuscitation. This book guides the reader, with the help of clarifying cartoons, through the basic principles and a new and easy to grasp system of interpretation.
Eine ganz entscheidende Rolle in der erfolgreichen Behandlung und PrAvention der Skelettdestruktion in der Osteologie und Onkologie kommt einer neuen Arzneimittelgruppe zu, den Bisphosphonaten. In den letzten drei Jahrzehnten hat diese Substanzgruppe einen Siegeszug in der klinischen Onkologie und Osteologie erlebt und dem Knochen die gebA1/4hrende Beachtung in der gesamten Medizin verschafft. Mit diesem kurz gefassten, klar gegliederten, klinisch orientierten und aufwendig illustrierten Manual werden die Struktur-Wirkungsbeziehungen der Bisphosphonate und deren Indikationen aufgezeigt und praktische Richtlinien fA1/4r Behandlungsstrategien und Anwendungen gegeben. Es ist kein Buch fA1/4r Knochenspezialisten, vielmehr ein A1/4bersichtlicher praktischer Ratgeber fA1/4r alle A"rzte, die sich A1/4ber Bisphosphonate informieren und Patienten erfolgreich behandeln wollen.
Coagulopathy (also called clotting disorder and bleeding disorder) is a condition in which the blood's ability to clot (coagulate) is impaired. Acquired hemophilia is a rare disorder characterized by spontaneous bleeding in a patient with no previous personal or family hemorrhagic history. The first chapter explores the challenges associated with this disease, its unfamiliarity often causing a delay in diagnosis and therapeutic approaches. The second chapter focuses on lower gastrointestinal bleeding (LGIB) in children, describing the epidemiology, etiology and clinical management. The third chapter reviews the pathogenesis, risk factors and treatment strategies of coagulopathy in patients with craniocerebral injury. The next article examines Vitamin B12 with its four cobalamin vitamers, which often play a role in coagulation. The next chapter starts with a description of the methodology of viscoelastic hemostatic assay, followed by a review of literature on the utilization of thrombelastography (TEG) or rotational thromboelastometry (ROTEM). Finally, the role of TEG and ROTEM to monitor or guide prophylaxis/treatment of thromboembolic events and the limitations of using them to detect hypercoagulability and identify patients with increased risks for thromboembolic complications are discussed. The final chapter of this book focuses on the use of fresh frozen plasma (FFP) in patients who are not actively bleeding, critically questions these assumptions in the context of pre-procedural administration of FFP, and also examines why carrying out high quality trails in this area has been so problematic. |
You may like...
|